ACE and McKesson Preparing to Reveal Earnings to Shareholders

ACE Limited (NYSE:ACE) will unveil its latest earnings on Tuesday, January 31, 2012. The average estimate of analysts is for profit of $1.83 per share, a decline of 10.7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.95. Between one and three months ago, the average estimate moved down. It also has dropped from $1.91 during the last month. Analysts are projecting profit to rise by 11.8% versus last year to $6.87.

The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 43 cents, reporting net income of $2.22 per share against a mean estimate of profit of $1.79 per share. On average, analysts predict $3.65 billion in revenue this quarter, a rise of 6.7% from the year ago quarter. Analysts are forecasting total revenue of $15.48 billion for the year, a rise of 12.9% from last year’s revenue of $13.71 billion.

Competitors to Watch: ACE Limited (NYSE:AEX), XL Group plc (NYSE:XL), Allied World Assurance Co Hldgs., AG. (NYSE:AWH), HCC Insurance Hldgs., Inc. (NYSE:HCC), Arch Capital Group Ltd. (NASDAQ:ACGL), American Intl. Group, Inc. (NYSE:AIG), American Financial Group (NYSE:AFG) and Aspen Insurance Hldgs. Ltd. (NYSE:AHL).

McKesson Corp (NYSE:MCK) will unveil its latest earnings on Monday, January 30, 2012. The average estimate of analysts is for net income of $1.37 per share, a rise of 22.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.52. Between one and three months ago, the average estimate moved down. It also has dropped from $1.38 during the last month. For the year, analysts are projecting profit of $6.33 per share, a rise of 29.2% from last year.

Last quarter, the company beat estimates by 25 cents, coming in at net income of $1.63 a share versus the estimate of profit of $1.38 a share. It marked the fourth straight quarter of beating estimates. On average, analysts predict $30.13 billion in revenue this quarter, a rise of 6.7% from the year ago quarter. Analysts are forecasting total revenue of $120.43 billion for the year, a rise of 7.5% from last year’s revenue of $112.08 billion.

Competitors to Watch: AmerisourceBergen Corp. (NYSE:ABC), Cardinal Health, Inc. (NYSE:CAH), Henry Schein, Inc. (NASDAQ:HSIC), Patterson Companies, Inc. (NASDAQ:PDCO), Cerner Corporation (NASDAQ:CERN), Owens & Minor, Inc. (NYSE:OMI), Omnicare, Inc. (NYSE:OCR), Grupo Casa Saba, S.A. (NYSE:SAB), MWI Veterinary Supply, Inc. (NASDAQ:MWIV), and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).